Conversion of human atrial or dermal fibroblasts into iPS cells or cardiomyocytes using a direct reprogramming strategy.

Conversion of human atrial or dermal fibroblasts into iPS cells or cardiomyocytes using a direct reprogramming strategy. - Derivation methods of human iPS cells and cardiomyocytes.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016798

Enrollment

100

Registered

2015-03-14

Start date

2012-08-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mase operation

Interventions

The exfoliative trial or dermal tissue after maze operation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: the patients who is performed by the maze operation.

Exclusion criteria

Exclusion criteria: nothing

Design outcomes

Primary

Measure	Time frame
Confirmation of expression level of representative anaplastic cells or cardiomyocytes by quantitative-PCR or western blot analysis. In case of iPS cells, we try to induce mesoderm induction of iPS cells into the cardiomyocytes.	—

Countries

Japan

Contacts

Public ContactTakaaki Senbonmatsu

International medical center Saitama Medical University Department of cardiology

senbont@saitama-med.ac.jp042-984-4733

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026